Zdislava Vaníčková

537 total citations
27 papers, 372 citations indexed

About

Zdislava Vaníčková is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Zdislava Vaníčková has authored 27 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Zdislava Vaníčková's work include Peptidase Inhibition and Analysis (7 papers), Microscopic Colitis (4 papers) and Celiac Disease Research and Management (4 papers). Zdislava Vaníčková is often cited by papers focused on Peptidase Inhibition and Analysis (7 papers), Microscopic Colitis (4 papers) and Celiac Disease Research and Management (4 papers). Zdislava Vaníčková collaborates with scholars based in Czechia, United States and Netherlands. Zdislava Vaníčková's co-authors include Aleksi Šedo, Z Límanová, E Kr̆epela, Jarmila Stremenova Spegarova, Jan Jiskra, Vladislav Mareš, Věra Lisá, Petr Bušek, Vladimír Dbalý and Julie E. Trim and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Zdislava Vaníčková

24 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zdislava Vaníčková Czechia 12 139 112 70 60 58 27 372
Julia M. Polak United Kingdom 9 87 0.6× 81 0.7× 54 0.8× 10 0.2× 77 1.3× 11 427
György Íllyés Hungary 10 58 0.4× 56 0.5× 45 0.6× 45 0.8× 32 0.6× 23 350
C B Lamers Netherlands 12 86 0.6× 78 0.7× 57 0.8× 65 1.1× 127 2.2× 18 453
Norma H. Rubin United States 11 116 0.8× 135 1.2× 32 0.5× 83 1.4× 25 0.4× 22 476
Angela L. Rachubinski United States 13 26 0.2× 146 1.3× 39 0.6× 39 0.7× 40 0.7× 25 535
Leonóra Himer Hungary 8 47 0.3× 127 1.1× 53 0.8× 16 0.3× 49 0.8× 8 557
Margaret Cook Canada 13 83 0.6× 122 1.1× 21 0.3× 12 0.2× 103 1.8× 27 465
Jessica Cioffi United States 9 162 1.2× 22 0.2× 139 2.0× 30 0.5× 35 0.6× 15 553
Hye-Yoon Lee South Korea 12 89 0.6× 212 1.9× 17 0.2× 16 0.3× 9 0.2× 51 490
Dilipkumar Parekh United States 10 305 2.2× 126 1.1× 109 1.6× 46 0.8× 110 1.9× 14 761

Countries citing papers authored by Zdislava Vaníčková

Since Specialization
Citations

This map shows the geographic impact of Zdislava Vaníčková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zdislava Vaníčková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zdislava Vaníčková more than expected).

Fields of papers citing papers by Zdislava Vaníčková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zdislava Vaníčková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zdislava Vaníčková. The network helps show where Zdislava Vaníčková may publish in the future.

Co-authorship network of co-authors of Zdislava Vaníčková

This figure shows the co-authorship network connecting the top 25 collaborators of Zdislava Vaníčková. A scholar is included among the top collaborators of Zdislava Vaníčková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zdislava Vaníčková. Zdislava Vaníčková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Šmalcová, Jana, Jacky Y. Suen, Zdislava Vaníčková, et al.. (2025). Intestinal fatty acid-binding protein as a marker of prognosis and non-occlusive mesenteric ischemia in refractory cardiac arrest patients: a pilot study. Resuscitation Plus. 24. 100972–100972. 1 indexed citations
2.
Vaníčková, Zdislava, et al.. (2025). Hair cortisol assessment of equine assisted therapy horses: Assessing long-term welfare and influencing management factors. Applied Animal Behaviour Science. 285. 106570–106570.
3.
Čermáková, Kateřina, et al.. (2024). Sensitive quantification of fibroblast activation protein and high-throughput screening for inhibition by FDA-approved compounds. European Journal of Medicinal Chemistry. 280. 116948–116948. 1 indexed citations
4.
Syrůček, Martin, Robert Tomáš, Zdislava Vaníčková, et al.. (2023). Fibroblast activation protein as a potential theranostic target in brain metastases of diverse solid tumours. Pathology. 55(6). 806–817. 16 indexed citations
5.
Uhrová, Jana, Hana Benaková, Zdislava Vaníčková, & Tomáš Zima. (2021). Comparison of the Chemiluminescence Immunoassay LIAISON® with the Radioimmunoassay for Aldosterone and Renin Measurement. SHILAP Revista de lepidopterología. 122(2). 80–95.
6.
Kr̆epela, E, Zdislava Vaníčková, Petr Hrabal, et al.. (2021). Regulation of Fibroblast Activation Protein by Transforming Growth Factor Beta-1 in Glioblastoma Microenvironment. International Journal of Molecular Sciences. 22(3). 1046–1046. 19 indexed citations
7.
Vaníčková, Zdislava, et al.. (2019). Canine-Assisted Therapy Improves Well-Being in Nurses. International Journal of Environmental Research and Public Health. 16(19). 3670–3670. 19 indexed citations
8.
Fišar, Zdeněk, Roman Jirák, Martina Zvěřová, et al.. (2019). Plasma amyloid beta levels and platelet mitochondrial respiration in patients with Alzheimer's disease. Clinical Biochemistry. 72. 71–80. 28 indexed citations
9.
Kr̆epela, E, et al.. (2017). Species-specific real-time RT-PCR analysis of expression of stromal cell genes in a tumor xenotransplantation model in mice. Biochemical and Biophysical Research Communications. 491(1). 126–133. 6 indexed citations
10.
Král, Aleš, Tomáš Kovárník, Zdislava Vaníčková, et al.. (2016). Cystatin C Is Associated with the Extent and Characteristics of Coronary Atherosclerosis in Patients with Preserved Renal Function. Folia Biologica. 62(6). 225–234. 7 indexed citations
11.
Bušek, Petr, Zdislava Vaníčková, Petr Hrabal, et al.. (2016). Increased tissue and circulating levels of dipeptidyl peptidase-IV enzymatic activity in patients with pancreatic ductal adenocarcinoma. Pancreatology. 16(5). 829–838. 31 indexed citations
12.
Vaníčková, Zdislava, et al.. (2013). Laboratory screening markers in gastroenterology - state of the art. Biomedical Papers. 157(2). 91–97. 1 indexed citations
13.
Zavoral, Miroslav, Tomáš Zima, Zák A, et al.. (2012). Improvements in colorectal cancer screening programmes - quantitative immunochemical faecal occult blood testing - how to set the cut-off for a particular population. Biomedical Papers. 156(2). 143–150. 6 indexed citations
14.
Uhrová, Jana, Helena Brodská, Zdislava Vaníčková, Hana Benaková, & Tomáš Zima. (2011). Procalcitonin interference in an immunometric calcitonin assay. Scandinavian Journal of Clinical and Laboratory Investigation. 71(2). 157–162. 3 indexed citations
15.
Spegarova, Jarmila Stremenova, Vladislav Mareš, Věra Lisá, et al.. (2010). Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas.. PubMed. 36(2). 351–8. 15 indexed citations
16.
Vaníčková, Zdislava, et al.. (2009). Methods of RNA Purification. All Ways (Should) Lead to Rome. Folia Biologica. 55(6). 243–251. 29 indexed citations
17.
Bartoš, Vladimı́r, et al.. (2007). Performance Characteristics of Seven Neuron-Specific Enolase Assays. Tumor Biology. 28(2). 84–92. 39 indexed citations
18.
Prázný, Martin, J Škrha, Z Límanová, et al.. (2005). Screening for associated autoimmunity in type 1 diabetes mellitus with respect to diabetes control. Physiological Research. 54(1). 41–48. 28 indexed citations
19.
20.
Vaníčková, Zdislava, et al.. (2002). Tissue Transglutaminase-Serology Markers for Coeliac Disease. Clinical Chemistry and Laboratory Medicine (CCLM). 40(5). 485–92. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julia M. Polak Breakdown of academic impact, for papers by György Íllyés Breakdown of academic impact, for papers by C B Lamers Breakdown of academic impact, for papers by Norma H. Rubin Breakdown of academic impact, for papers by Angela L. Rachubinski Breakdown of academic impact, for papers by Leonóra Himer Breakdown of academic impact, for papers by Margaret Cook Breakdown of academic impact, for papers by Jessica Cioffi Breakdown of academic impact, for papers by Hye-Yoon Lee Breakdown of academic impact, for papers by Dilipkumar Parekh
Rankless by CCL
2026